Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05486091 · ClinicalTrials.gov registry record · NA
A Feasibility Open Trial of App-Enhanced Brief CBT for Suicidal Inpatients
A NA study, sponsored by Hartford Hospital.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT05486091: Completed NA study, sponsored by Hartford Hospital.
NCT05486091 is a NA study that has completed, run by Hartford Hospital. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05486091, a NA study, has completed, sponsored by Hartford Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the feasibility of integrating Brief Cognitive-Behavioral Therapy (BCBT) counseling with a software application (app) to prevent future suicidal thoughts and behaviors.
Primary Outcome
The Client Satisfaction Questionnaire (CSQ) contains 8 multiple choice items and assesses the acceptability and satisfaction of the study treatment. Items are rated from 1 to 4. Items are added together for a total score ranging from 8 to 32 with higher numbers representing greater satisfaction with the treatment. The mean and standard deviation for the CSQ total score will be reported utilizing all available data.
Interventions
- BEHAVIORAL App-Enhanced Brief Cognitive-Behavioral Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2022-10-03 |
| Est. Completion | 2023-02-15 |
| Phase | NA |
What the finished NCT05486091 record still lists
NCT05486091 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which App-Enhanced Brief Cognitive-Behavioral Therapy is the first listed.
NCT05486091 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05486091 about?
NCT05486091 is a clinical study titled "A Feasibility Open Trial of App-Enhanced Brief CBT for Suicidal Inpatients". The purpose of this study is to evaluate the feasibility of integrating Brief Cognitive-Behavioral Therapy (BCBT) counseling with a software application (app) to prevent future suicidal thoughts and behaviors.
What is the current status of trial NCT05486091?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2022-10-03. Estimated completion is 2023-02-15.
What interventions are being tested in trial NCT05486091?
The interventions under investigation include: App-Enhanced Brief Cognitive-Behavioral Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT05486091?
This trial is sponsored by Hartford Hospital, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05486091's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI